Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options

被引：15
作者：
Licitra, L. [1 ]
Locati, L. D. [1 ]
Bossi, P. [1 ]
机构：
[1] Ist Nazl Tumori, Fdn IRCCS, Head & Neck Med Oncol Unit, Dept Med Oncol, I-20133 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
10.1093/annonc/mdn456
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 203
页数：4
相关论文
共 44 条
[11]   A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck [J].
Colevas, AD ;
Adak, S ;
Amrein, PC ;
Barton, JJ ;
Costello, R ;
Posner, MR .
ANNALS OF ONCOLOGY, 2000, 11 (05) :535-539
[12]   A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck [J].
Couteau, C ;
Chouaki, N ;
Leyvraz, S ;
Oulid-Aissa, D ;
Lebecq, A ;
Domenge, C ;
Groult, V ;
Bordessoule, S ;
Janot, F ;
De Forni, M ;
Armand, JP .
BRITISH JOURNAL OF CANCER, 1999, 81 (03) :457-462
[13]   Docetaxel: An active drug for squamous cell carcinoma of the head and neck [J].
Dreyfuss, AI ;
Clerk, JR ;
Norris, CM ;
Rossi, RM ;
Lucarini, JW ;
Busse, PM ;
Poulin, MD ;
Thornhill, L ;
Costello, R ;
Posner, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1672-1678
[14]   The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck [J].
Eriksen, JG ;
Steiniche, T ;
Askaa, J ;
Alsner, J ;
Overgaard, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (02) :561-566
[15]  
Ferlay J, 2004, GLOBOCAN 2002 CANC I
[16]   RANDOMIZED COMPARISON OF CISPLATIN PLUS FLUOROURACIL AND CARBOPLATIN PLUS FLUOROURACIL VERSUS METHOTREXATE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].
FORASTIERE, AA ;
METCH, B ;
SCHULLER, DE ;
ENSLEY, JF ;
HUTCHINS, LF ;
TRIOZZI, P ;
KISH, JA ;
MCCLURE, S ;
VONFELDT, E ;
WILLIAMSON, SK ;
VONHOFF, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) :1245-1251
[17]   Does histologic grade have a role in the management of head and neck cancers? [J].
Fortin, A ;
Couture, C ;
Doucet, R ;
Albert, M ;
Allard, J ;
Tetu, B .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (21) :4107-4116
[18]   Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck [J].
Gedlicka, C ;
Formanek, M ;
Selzer, E ;
Burian, M ;
Kornfehl, J ;
Fiebiger, W ;
Cartellieri, M ;
Marks, B ;
Kornek, GV .
ONCOLOGY, 2002, 63 (02) :145-150
[19]   Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck - A Phase II Multicenter Study [J].
Genet, D ;
Cupissol, D ;
Calais, G ;
Bontemps, P ;
Bourgeois, H ;
Dutin, JP ;
Philippi, MH ;
Bendahmane, B ;
Mallard-Carre, M ;
Tubiana-Mathieu, N .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (05) :472-476
[20]   Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group [J].
Gibson, MK ;
Li, Y ;
Murphy, B ;
Hussain, MHA ;
DeConti, RC ;
Ensley, J ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3562-3567
12345